Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alan F. Cowman, Ph.D.

Co-Author

This page shows the publications co-authored by Alan Cowman and Manoj Duraisingh.
Connection Strength

3.437
  1. The Molecular Basis of Erythrocyte Invasion by Malaria Parasites. . 2017 Aug 09; 22(2):232-245.
    View in: PubMed
    Score: 0.766
  2. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005 Jun; 94(3):181-90.
    View in: PubMed
    Score: 0.329
  3. Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum. Cell. 2005 Apr 08; 121(1):13-24.
    View in: PubMed
    Score: 0.326
  4. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc Natl Acad Sci U S A. 2003 Apr 15; 100(8):4796-801.
    View in: PubMed
    Score: 0.283
  5. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J. 2003 Mar 03; 22(5):1047-57.
    View in: PubMed
    Score: 0.282
  6. Negative selection of Plasmodium falciparum reveals targeted gene deletion by double crossover recombination. Int J Parasitol. 2002 Jan; 32(1):81-9.
    View in: PubMed
    Score: 0.260
  7. An old enemy, a new battle plan. Perspective on combating drug-resistant malaria. . 2001 Feb; 2(2):77-9.
    View in: PubMed
    Score: 0.244
  8. Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex. Nature. 2019 01; 565(7737):118-121.
    View in: PubMed
    Score: 0.210
  9. Cooperativity between Plasmodium falciparum adhesive proteins for invasion into erythrocytes. Mol Microbiol. 2009 May; 72(3):578-89.
    View in: PubMed
    Score: 0.108
  10. Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum. PLoS Biol. 2009 Apr 14; 7(4):e84.
    View in: PubMed
    Score: 0.108
  11. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science. 2005 Aug 26; 309(5739):1384-7.
    View in: PubMed
    Score: 0.084
  12. Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol Microbiol. 2005 Jan; 55(1):162-74.
    View in: PubMed
    Score: 0.080
  13. Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. Am J Trop Med Hyg. 2003 Mar; 68(3):350-6.
    View in: PubMed
    Score: 0.070
  14. A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J Biol Chem. 2003 Apr 18; 278(16):14480-6.
    View in: PubMed
    Score: 0.070
  15. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med. 2003 Jan; 9(1):87-92.
    View in: PubMed
    Score: 0.069
  16. Identification and disruption of the gene encoding the third member of the low-molecular-mass rhoptry complex in Plasmodium falciparum. Infect Immun. 2002 Sep; 70(9):5236-45.
    View in: PubMed
    Score: 0.068
  17. Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development. Philos Trans R Soc Lond B Biol Sci. 2002 Jan 29; 357(1417):25-33.
    View in: PubMed
    Score: 0.065
  18. A genetic screen for improved plasmid segregation reveals a role for Rep20 in the interaction of Plasmodium falciparum chromosomes. EMBO J. 2002 Mar 01; 21(5):1231-9.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.